These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6768216)

  • 1. Cyclic oscillations in leukocyte count in chronic myeloid leukemia.
    Mehta BC; Agarwal MB
    Acta Haematol; 1980; 63(2):68-70. PubMed ID: 6768216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy.
    Kennedy BJ
    Blood; 1970 Jun; 35(6):751-60. PubMed ID: 5269413
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia.
    Rushing D; Goldman A; Gibbs G; Howe R; Kennedy BJ
    Am J Clin Oncol; 1982 Jun; 5(3):307-13. PubMed ID: 6952759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Cancer; 1972 Apr; 29(4):1052-6. PubMed ID: 4552811
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of chronic myelocytic leukemia.
    Galton DA
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyurea therapy in chronic myeloid leukemia.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jul; 30(7):427-8. PubMed ID: 6963266
    [No Abstract]   [Full Text] [Related]  

  • 8. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia.
    Bolin RW; Robinson WA; Sutherland J; Hamman RF
    Cancer; 1982 Nov; 50(9):1683-6. PubMed ID: 6956430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of chronic granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1977 Dec; 137(12):1717-8. PubMed ID: 270965
    [No Abstract]   [Full Text] [Related]  

  • 10. Current concepts in chronic myelogenous leukemia.
    Stryckmans PA
    Semin Hematol; 1974 Apr; 11(2):101-27. PubMed ID: 4595812
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic oscillations of leucocyte counts in chronic myeloid leukaemia.
    Malhotra OP; Salam SR
    Postgrad Med J; 1991 Jan; 67(783):87-9. PubMed ID: 2057439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic irradiation following chemotherapy in chronic myelogenous leukemia.
    Wilson JF; Johnson RE
    Radiology; 1971 Dec; 101(3):657-61. PubMed ID: 5288778
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 14. [The busulfan therapy of chronic granulocytic leukemia].
    Kinugasa K; Takaku F; Sassa S; Chiba S; Mizoguchi H
    Nihon Naika Gakkai Zasshi; 1969 Nov; 58(11):1191-6. PubMed ID: 5261216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V
    Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.
    Schwartz JH; Cannellos GP
    Blood; 1975 Jul; 46(1):11-6. PubMed ID: 1055610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phase.
    Schwarzenberg L; Mathé G; Pouillart P; Weiner R; Locour J; Genin J; Schneider M; De Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Br Med J; 1973 Mar; 1(5855):700-3. PubMed ID: 4512003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia].
    Kiss A; Jakó J; Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):275-80. PubMed ID: 6168539
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetic criteria of the effectiveness of treatment of chronic myeloleukosis].
    Levitin EI; Kukharenko IuA; Gor'kov VA; Evseenko LS
    Izv Akad Nauk SSSR Biol; 1973; 4():566-72. PubMed ID: 4518679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Regularities in the change in leukocyte count during treatment of chronic myeloid leukosis].
    Emanuél' NM; Sherman SI; Levitin EI; Rozanova LM; Evseenko LS; Kukharenko IuA
    Dokl Akad Nauk SSSR; 1967 Aug; 175(5):1197-200. PubMed ID: 5270825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.